1. Clasificación por tamaño de unidad

  • STR (microsatélites): 1-6 pb → grueso de patología neurológica
  • VNTR (sentido amplio): número variable de copias, unidad mayor
  • Minisatélites clásicos: 10-60 pb (INS, MUC1)
  • Macrosatélites: miles de pb — mismo principio (nº variable de copias), unidad muchísimo mayor (FSHD/D4Z4)

2. Por qué son inestables (mecanismo común)

  • Deslizamiento de la ADN polimerasa durante replicación
  • Hebra naciente se disocia y reasocia en registro desplazado → bucle
  • Bucle en hebra naciente → expansión
  • Bucle en hebra molde → contracción
  • A mayor longitud previa, mayor probabilidad de bucle → inestabilidad no lineal tras umbral crítico (normal → premutación → mutación completa)

Consecuencia clínica: anticipación genética = manifestación fenotípica de esta inestabilidad meiótica creciente (sesgo paterno o materno según la enfermedad).

3. Tres mecanismos según localización de la repetición (bloque STR)

A) Exón codificante, tripletes (CAG=poliQ)

  • Proteína anómala con tracto de poliglutamina
  • Mal plegamiento → agregación intranuclear
  • Ganancia de función tóxica, dominante
  • Ej.: Huntington, SCAs, Kennedy (ligada a X)

B) Región no codificante (UTR, intrón), gran expansión

  • Silenciamiento epigenético → hipermetilación → pérdida de función (X frágil, Friedreich)
  • Toxicidad de ARN → secuestro de proteínas de splicing por ARN mensajero con repetición expandida (miotónica, C9orf72)
STR引起的神经系统疾病。
缩写表型(MIM 编号)基因继承方式重复主题基因上的位置致病性重复次数a染色体坐标 (hg38)临床表型参考
C9-FTD
C9-ALS
(#10550)
C9orf72广告。GGGGCC5' 区域24–4000chr92757348527573546额颞叶痴呆、肌萎缩侧索硬化症[32, 47, 65]
帆布
(#614575)
RFC1A.R.(阿格格)400–2000
(ACAG)经验值
AAAAG(正常)
内含子2400–2000染色体43934842539348483小脑性共济失调、神经病和前庭无反射综合征[11, 28, 138]
DM1
(#160900)
DMPK广告。CTG
(中断:CCG)
3’区域50–10,000第19位基因4577020545770266强直性肌营养不良1[60, 176]
DM2
(#602668)
中国国家石油公司 (ZNF9)广告。CCTG内含子150–11,000chr3129172577129172656强直性肌营养不良2[176]
DRPLA
(#125370)
ATN1广告。冠状动脉造影外显子549–93chr1269367176936775齿状红核-苍白球路易体萎缩[78]
EIEE1/XLID
(#308350)
(#300419)
(#300215)
阿尔克斯XL海湾合作委员会外显子217–27chrX2501365425013697疾病的临床谱,包括发育性脑病和癫痫性脑病 1、伴有生殖器异常的积水性无脑畸形、X 连锁无脑畸形 2 和 X 连锁智力低下 29[73, 150]
名誉1 (#601068)SAMD12广告。TTCA
在 TTTTA 重复区域内
内含子4105–3680chr8118366813118366918家族性成人肌阵挛性癫痫 1[22, 68]
FAME2
(#607876)
标准7广告。ATTTC
在 ATTTT 重复区域内
内含子1150–460chr29619706796197124家族性成人肌阵挛性癫痫2[27]
FAME3
(#613608)
3月6日广告。TTCA
在 TTTTA 重复区域内
内含子1700–1035chr51035633910356411家族性成人肌阵挛性癫痫 3[40]
FAME6
(#618074)
TNRC6A广告。TTCA
在 TTTTA 重复区域内
内含子1?
(只有1个家庭)
chr162461343924613532家族性成人肌阵挛性癫痫 6[68]
FAME7
(#618075)
RAPGEF2广告。TTCA
在 TTTTA 重复区域内
内含子14?
(只有1个家庭)
染色体4159342527159342618家族性成人肌阵挛性癫痫 7[68]
弗拉克斯
(#309548)
FMR2 (AF2)卡侬海湾合作委员会5' 区域 > 200chrX148500605148500753精神发育迟滞,X连锁,FRAXE型[53]
FRDA
(#229300)
FXNA.R.GAA内含子166–1300chr96903727569037314弗里德赖希共济失调[5, 19, 162]
FXS
(#300624)
福克斯塔斯
(#300623)
FMR1XLCGG5' 区域200–3000
55–200
chrX147911979147912111脆性X综合征
脆性 X 震颤/共济失调综合征、卵巢早衰 1
[162]
[56]
高清
(#143100)
高温试验广告。冠状动脉造影
(中断:CAA)
外显子136–250染色体430748763074941亨廷顿病[96, 101]
高密度脂蛋白1
(#603218)
PRNP广告。24碱基
八肽 PHGGGWGQ
外显子28–14chr2046993794699380亨廷顿病样 1[108]
高密度脂蛋白2
(#606438)
JPH3广告。CTG外显子2A40–59chr168760428387604329亨廷顿病样2[62]
汉密尔顿大众WA1A.R.GGCGCGGAGC外显子13chr114357991435820遗传性轴突运动神经病[121]
NIID
(#603472)
NOTCH2NLC广告。CGG5′区域66–517chr1149390803149390842神经元核内包涵体病[55, 118, 146]
OPDM1
(#164310)
LRP12广告。CGG5′区域90–130chr8104588965104588999眼咽远端肌病[69]
OPDM2
(#618940)
GIPC1广告。CGG5' 区域70–164第19位基因1449602914496104眼咽远端肌病[172]
OPMD
(#164300)
PABPN1广告。G.C.G.外显子17–18chr142332147223321511眼咽肌营养不良症[15, 129]
OPML1
(#618637)
NUTM2B-AS1广告。CGG5′区域16–160chr107982636479826403眼咽肌病伴白质脑病 1[69]
SBMA
(#313200)
A.R.卡侬冠状动脉造影外显子138–68chrX6754531767545419肯尼迪脊髓和延髓肌萎缩症(肯尼迪病)[44, 82, 147]
SCA1
(#164400)
ATXN1广告。冠状动脉造影
(中断:CAT)
外显子839–91chr61632763616327723脊髓小脑共济失调1[120, 141]
SCA2
(#183090)
ATXN2广告。冠状动脉造影
(中断:CAA、CGG、CGC)
外显子133–200
(29–32
ALS 风险增加)
chr12111598950111599019脊髓小脑共济失调2[18, 133, 141, 148]
SCA3
(#109150)
ATXN3广告。冠状动脉造影外显子1053–87chr149207101192071052脊髓小脑共济失调3[74]
SCA6
(183086)
CACNA1A广告。冠状动脉造影外显子 4719–33第19位基因1320785813207897脊髓小脑共济失调 6[141, 181]
SCA7
(#164500)
ATXN7广告。冠状动脉造影外显子134–460chr36391268563912716脊髓小脑共济失调7[18, 30]
SCA8
(#608768)
ATXN8广告。CAG/标签3'UTR74–1300chr137013938370139428脊髓小脑共济失调8[79, 141, 155]
SCA10
(#603516)
ATXN10广告。ATTCT
(中断:ATCCT)
内含子9280–4500chr224579535545795424脊髓小脑共济失调 10[88, 100, 141]
SCA12
(#604326)
PPP2R2B广告。冠状动脉造影5' 区域51–78chr5146878729146878758脊髓小脑共济失调 12[63, 94, 141]
SCA17
(#607136)
待定时间广告。冠状动脉造影
(中断:CAT、CAA)
外显子343–66chr6170561907170562017脊髓小脑性共济失调 17,亨廷顿病样 4[97, 115, 141]
SCA31
(#117210)
豆1广告。TGAA
在 TAAAA 和 TAGAA 重复区域内
内含子/
基因间区
500–760
(> 110 TGGAA 重复)
chr166649547566495509脊髓小脑共济失调 31[134]
SCA36
(#614153)
诺普56广告。GGCCTG内含子1650–2500chr2026527332652775脊髓小脑共济失调 36[77]
SCA37
(#615945)
DAB1广告。ATTTC
在(ATTTT)内7–400 重复区域
5' 区域31–75chr15736704457367125脊髓小脑共济失调 37[139]
集装式
(#254800)
科学技术委员会A.R.CCCCGCCCCGCG上游
5'UTR
30–125chr214377644443776479进行性肌阵挛癫痫 1A(Unverricht 和 Lundborg 病)[87, 91]
ALS,肌萎缩侧索硬化症; AS,反义RNA; CANVAS、小脑性共济失调神经病和前庭反射消失综合征; DM1;强直性肌营养不良1; DM2;强直性肌营养不良2; DRPLA,齿状核红核-苍白球路易体萎缩; EIEE1,早期婴儿癫痫性脑病1; FAME,家族性成人肌阵挛性癫痫; FRAXE,脆弱-XE 综合征; FRDA,弗里德赖希共济失调; FTD,额颞叶痴呆; FXS,脆性 X 综合征; FXTAS,脆性 x 震颤/共济失调综合征; HMN,遗传性运动神经病; HD,亨廷顿病; HDL2,亨廷顿病样 2; HDL1,亨廷顿病样 1; LMN,下运动神经元; NIID-- 神经元核内包涵体病; OPDM,眼咽远端肌病; OPMD-- 眼咽肌营养不良症; OPML,眼咽肌病伴白质脑病; SBMA,脊髓和延髓肌萎缩症; SCA,脊髓小脑共济失调; ULD,Unverricht-Lundborg 病; UMN,上运动神经元; XLID,x 连锁智力障碍;
a这些范围因研究而异,并且上限通常未知。值得注意的是,这些仅具有潜在致病性。健康对照人群中有一小部分(< 1%)具有扩展的等位基因,但没有临床表现。同样,低于给定范围的等位基因可能具有中间等位基因和前突变综合征
STR引起的先天性和发育性疾病。
表型 (OMIM#)基因主题致病性重复次数地点(HG38)参考
BPES
(#110100)
FOXL2G.C.G.22-24日外显子chr3138946022138946062[116]
CCHS
(#209880)
PHOX2BG.C.G.24–33外显子染色体44174597641746022[7]
数据库QD2
(#615777)
XYLT1GGC100–8005' 区域chr161747086917470967[86]
FECD3
(#613267)
TCF4热气相色谱法 > 50内含子chr18a55222184a55635956a[167]
国内生产总值总局
(#618412)
格力斯GCA > 3005' 区域chr2190880873190880920[159]
H.F.G.
(#140000)
HOXA13G.C.G.24–26外显子chr72719982727199967[50]
惠普E5
(#609637)
ZIC2G.C.G.25外显子chr139998544999985494[17]
哈桑8
(#616488)
PRDM12G.C.G.18–19外显子chr9130681606130681641[23]
防雷器1
(#186000)
霍克斯D13G.C.G.22–29外显子chr2176093058176093099[2]
XLMR
(#300123)
硫氧化物3G.C.G.15–26外显子chr3181712415181712456[89]
BPES、睑裂、内眦赘皮和上睑下垂; CCHS,先天性中枢性通气不足综合征; DBQD2,Desbuquois 发育不良 2; FECD3,福克斯内皮性角膜营养不良3; GDPAG、整体发育迟缓、进行性共济失调和谷氨酰胺升高; HFG,手足生殖器综合症; HPE5,前脑无裂畸形 5; SPD1,并指多趾症1; XLMR,x连锁智力低下
a列出整个基因的位置

4. Bloque VNTR (sentido amplio)

Minisatélites clásicos

  • Variación de número de copias sin umbral patogénico brusco
  • Modulan riesgo poligénico (INS → diabetes tipo 1) o causan enfermedad estructural (MUC1 → ADTKD)
  • Base histórica del «DNA fingerprinting» forense

Macrosatélites

— FSHD como caso paradigmático

  • D4Z4 (subtelómero 4q35): unidad de 3.3 kb
  • Normal: 11-100 copias / Patológico: ≤10 copias (FSHD1) — contracción, no expansión
  • Contracción abre cromatina → desrepresión de DUX4 (normalmente silenciado en músculo adulto) → toxicidad
  • Requiere haplotipo permisivo 4qA (misma contracción en 4qB no causa enfermedad)
  • FSHD2: array normal, pero mutación en SMCHD1 → mismo resultado (desrepresión de DUX4) por vía trans, no por contracción cis
  • No sigue anticipación genética clásica (mecanismo epigenético, no carrera de repeticiones)
  • Sí, hay un grupo pequeño pero importante de enfermedades que comparten con FSHD el mecanismo «atípico» (repetición grande, no microsatélite clásico, y/o mecanismo epigenético en vez de toxicidad directa). Las más relevantes para tu esquema:

—- Síndrome ICF (Inmunodeficiencia, Inestabilidad Centromérica, anomalías Faciales)

  • Afecta repeticiones satélite 2 y 3 (secuencias pericentroméricas, no D4Z4, pero mismo principio de macrosatélite/heterocromatina repetitiva)
  • Mecanismo: mutaciones en DNMT3B (o ZBTB24, CDCA7, HELLS) → hipometilación de estas regiones repetidas → descondensación pericentromérica → inestabilidad cromosómica
  • Es prácticamente el equivalente autosómico recesivo del mecanismo de FSHD2: falla la maquinaria que mantiene silenciada la heterocromatina repetitiva, en vez de fallar la repetición misma

—- Epilepsia mioclónica progresiva tipo 1 (Unverricht-Lundborg).

  • Gen 科学技术委员会 (cistatina B)
  • Repetición dodecámera (12 pb) en el promotor — tamaño frontera entre microsatélite y minisatélite, otro caso que no encaja limpiamente en STR clásico
  • Mecanismo: expansión (a diferencia de FSHD) pero el resultado es pérdida de función por reducción transcripcional, no toxicidad de proteína ni de ARN — la expansión en el promotor simplemente dificulta la transcripción del gen
  • Útil como contraste: expansión que causa pérdida de función pura, sin ganancia tóxica
19955111 {19955111:N989PCPW},{19955111:XHVJIQA4} 1 温哥华 50 默认 2455 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22N989PCPW%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Depienne%20and%20Mandel%22%2C%22parsedDate%22%3A%222021-05-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BDepienne%20C%2C%20Mandel%20JL.%2030%20years%20of%20repeat%20expansion%20disorders%3A%20What%20have%20we%20learned%20and%20what%20are%20the%20remaining%20challenges%3F%20The%20American%20Journal%20of%20Human%20Genetics%20%5BInternet%5D.%202021%20May%206%20%5Bcited%202021%20Sept%2019%5D%3B108%285%29%3A764%26%23x2013%3B85.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0002929721000951%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0002929721000951%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%2230%20years%20of%20repeat%20expansion%20disorders%3A%20What%20have%20we%20learned%20and%20what%20are%20the%20remaining%20challenges%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Depienne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Mandel%22%7D%5D%2C%22abstractNote%22%3A%22Tandem%20repeats%20represent%20one%20of%20the%20most%20abundant%20class%20of%20variations%20in%20human%20genomes%2C%20which%20are%20polymorphic%20by%20nature%20and%20become%20highly%20unstable%20in%20a%20length-dependent%20manner.%20The%20expansion%20of%20repeat%20length%20across%20generations%20is%20a%20well-established%20process%20that%20results%20in%20human%20disorders%20mainly%20affecting%20the%20central%20nervous%20system.%20At%20least%2050%20disorders%20associated%20with%20expansion%20loci%20have%20been%20described%20to%20date%2C%20with%20half%20recognized%20only%20in%20the%20last%20ten%20years%2C%20as%20prior%20methodological%20difficulties%20limited%20their%20identification.%20These%20limitations%20still%20apply%20to%20the%20current%20widely%20used%20molecular%20diagnostic%20methods%20%28exome%20or%20gene%20panels%29%20and%20thus%20result%20in%20missed%20diagnosis%20detrimental%20to%20affected%20individuals%20and%20their%20families%2C%20especially%20for%20disorders%20that%20are%20very%20rare%20and%5C%2For%20clinically%20not%20recognizable.%20Most%20of%20these%20disorders%20have%20been%20identified%20through%20family-driven%20approaches%20and%20many%20others%20likely%20remain%20to%20be%20identified.%20The%20recent%20development%20of%20long-read%20technologies%20provides%20a%20unique%20opportunity%20to%20systematically%20investigate%20the%20contribution%20of%20tandem%20repeats%20and%20repeat%20expansions%20to%20the%20genetic%20architecture%20of%20human%20disorders.%20In%20this%20review%2C%20we%20summarize%20the%20current%20and%20most%20recent%20knowledge%20about%20the%20genetics%20of%20repeat%20expansion%20disorders%20and%20the%20diversity%20of%20their%20pathophysiological%20mechanisms%20and%20outline%20the%20perspectives%20of%20developing%20personalized%20treatments%20in%20the%20future.%22%2C%22date%22%3A%22May%206%2C%202021%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajhg.2021.03.011%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0002929721000951%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220002-9297%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22QKPQST8L%22%5D%2C%22dateModified%22%3A%222026-07-15T22%3A41%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22XHVJIQA4%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chintalaphani%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BChintalaphani%20SR%2C%20Pineda%20SS%2C%20Deveson%20IW%2C%20Kumar%20KR.%20An%20update%20on%20the%20neurological%20short%20tandem%20repeat%20expansion%20disorders%20and%20the%20emergence%20of%20long-read%20sequencing%20diagnostics.%20Acta%20Neuropathologica%20Communications%20%5BInternet%5D.%202021%20May%2025%20%5Bcited%202021%20Sept%2019%5D%3B9%281%29%3A98.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40478-021-01201-x%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40478-021-01201-x%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20update%20on%20the%20neurological%20short%20tandem%20repeat%20expansion%20disorders%20and%20the%20emergence%20of%20long-read%20sequencing%20diagnostics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjog%20R.%22%2C%22lastName%22%3A%22Chintalaphani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandy%20S.%22%2C%22lastName%22%3A%22Pineda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ira%20W.%22%2C%22lastName%22%3A%22Deveson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kishore%20R.%22%2C%22lastName%22%3A%22Kumar%22%7D%5D%2C%22abstractNote%22%3A%22Short%20tandem%20repeat%20%28STR%29%20expansion%20disorders%20are%20an%20important%20cause%20of%20human%20neurological%20disease.%20They%20have%20an%20established%20role%20in%20more%20than%2040%20different%20phenotypes%20including%20the%20myotonic%20dystrophies%2C%20Fragile%20X%20syndrome%2C%20Huntington%5Cu2019s%20disease%2C%20the%20hereditary%20cerebellar%20ataxias%2C%20amyotrophic%20lateral%20sclerosis%20and%20frontotemporal%20dementia.%22%2C%22date%22%3A%22May%2025%2C%202021%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs40478-021-01201-x%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40478-021-01201-x%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222051-5960%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%22QKPQST8L%22%5D%2C%22dateModified%22%3A%222026-05-09T07%3A43%3A45Z%22%7D%7D%5D%7D
1.
Depienne C, Mandel JL. 30 years of repeat expansion disorders: What have we learned and what are the remaining challenges? The American Journal of Human Genetics [Internet]. 2021 May 6 [cited 2021 Sept 19];108(5):764–85. Available from: https://www.sciencedirect.com/science/article/pii/S0002929721000951
1.
Chintalaphani SR, Pineda SS, Deveson IW, Kumar KR. An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathologica Communications [Internet]. 2021 May 25 [cited 2021 Sept 19];9(1):98. Available from: https://doi.org/10.1186/s40478-021-01201-x